Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Astellas Pharma Posts 17% Q1 Sales Growth Driven by Xtandi and Padcev
February 17, 2025
Drug
Eli Lilly’s Taltz Wins Second NMPA Approval for Ankylosing Spondylitis
February 17, 2025
Company
Deals
China Resources Double-Crane to Acquire Stake in Shenzhou Biotech for Bio-Fermentation Push
February 17, 2025
Company
Deals
Coherent Biopharma Raises Series B Funds to Advance Bi-XDC Pipeline
February 17, 2025
Company
Drug
Hengrui Medicine’s Pyrotinib Combo Meets Endpoints in HER2+ Breast Cancer Trial
February 17, 2025
Company
Drug
Shouyao Holdings Receives Approval for CT-3505 ALK Inhibitor Study in NSCLC
February 17, 2025
Company
Drug
InnoCare Pharma Doses First Patient in ICP-488 Study for Autoimmune Diseases
February 17, 2025
Company
Deals
Convalife Pharmaceuticals Licenses Karus Therapeutics’ CVL237 Globally
February 17, 2025
Company
Deals
Unicycive Therapeutics Licenses Renazorb to Lee’s Pharma for Asian Markets
February 17, 2025
Company
Drug
HutchMed Initiates China Bridging Study for Tazverik in Follicular Lymphoma
February 17, 2025
Company
Deals
Hainan Shuangcheng to Transfer Triptorelin Assets to Chongqing Lummy for USD 4.7M
February 17, 2025
Company
Drug
Eccogene Receives FDA Approval for ECC4703 Phase I Study in NASH and Dyslipidemia
February 17, 2025
1
2
…
1,160
1,161
1,162
1,163
1,164
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?